MedPath

Haemophilus Influenzae Pneumonia in Adults

Not yet recruiting
Conditions
Haemophilus Influenzae Pneumonia
Interventions
Other: Collection of data from the patient's medical file
Registration Number
NCT06517277
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

Haemophilus influenzae is a Gram-negative coccobacillus capable of colonizing and infecting the human respiratory tract.

In the adult population, patients with an abnormality of their mucociliary epithelium and a deficiency in innate or adaptive immunity are particularly exposed.

The Infectious and Tropical Diseases department of Necker-Enfants Malades hospital has noted a recent increase in the number of cases of respiratory infections due to H. influenzae, with a high frequency of early relapses and recurrences despite appropriate treatment.

The research focuses on lower respiratory infections (pneumonia) caused by Haemophilus influenzae in adults, excluding pneumonia acquired under mechanical ventilation linked to Haemophilus influenzae in patients in 13 AP-HP hospitals during 12 months, from 09/01/2022 to 08/31/2023.

Detailed Description

Haemophilus influenzae is a Gram-negative coccobacillus capable of colonizing and infecting the human respiratory tract.

In the adult population, patients with an abnormality of their mucociliary epithelium and a deficiency in innate or adaptive immunity are particularly exposed.

The Infectious and Tropical Diseases department of Necker-Enfants Malades hospital has noted a recent increase in the number of cases of respiratory infections due to H. influenzae, with a high frequency of early relapses and recurrences despite appropriate treatment.

The research focuses on lower respiratory infections (pneumonia) caused by Haemophilus influenzae in adults, excluding pneumonia acquired under mechanical ventilation linked to Haemophilus influenzae in patients in 13 AP-HP hospitals during 12 months, from 09/01/2022 to 08/31/2023.

The main objective of the study is to identify factors associated with relapse in hospitalized adult Haemophilus influenzae pneumonia.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Acute respiratory symptoms: cough and/or dyspnea and/or purulent sputum or worsening of the color of the sputum for patients with chronic respiratory pathology, chest pain, desaturation defined by saturation < 95% in ambient air
  • Inflammatory syndrome: fever ≥ 38.5°C or CRP ≥ 30 mg/L
  • Pulmonary imaging (x-ray or CT scan) compatible with pneumonia
  • Good quality respiratory sample (for cytobacteriological examination of sputum (CBES) : leukocytes > 25/mm3 and cells < 10/mm3) positive in culture for H. influenzae at a significant threshold (for CBES ≥ 107 CFU/mL, for "standard" bronchial aspirate ≥ 105 CFU/mL, for protected bronchial aspiration ≥ 103 CFU/mL, for bronchoalveolar lavage ≥ 104 CFU/mL)
  • Respiratory antibiotic therapy started by the clinician
Read More
Exclusion Criteria
  • Age < 18 years
  • Opposition formulated (following receipt of the study information note)
  • Legal protection measure (impossibility of collecting non-opposition)
  • Ventilator-associated pneumonia (VAP)
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PatientsCollection of data from the patient's medical fileHospitalized patients for a Haemophilus influenzae pneumonia in 13 AP-HP hospitals between 09/01/2022 to 08/31/2023.
Primary Outcome Measures
NameTimeMethod
Relapse associated factors of Haemophilus influenzae pneumonia15 months

Relapse associated factors with the Haemophilus influenzae pneumonia in hospitalized adult.

Relapse of Haemophilus influenzae pneumonia defined as:

* Definite relapse: acute respiratory symptoms (cough and/or dyspnea and/or purulent sputum), inflammatory syndrome (clinical: fever ≥ 38.5°C or biological: CRP ≥ 30 mg/L), respiratory antibiotic therapy started by the clinician, new good quality respiratory sample positive in culture for Haemophilus influenzae within 90 days following the first episode.

* Probable relapse: acute respiratory symptoms, inflammatory syndrome (clinical: fever ≥ 38.5°C or biological: CRP ≥ 30 mg/L), respiratory antibiotic therapy started by the clinician, absence of microbiological documentation of the new episode, within 30 days following the first episode.

Secondary Outcome Measures
NameTimeMethod
Pulmonary radiological patterns in Haemophilus influenzae pneumonia15 months

Describe the pulmonary radiological patterns associated with Haemophilus influenzae pneumonia.

Severity associated factors in Haemophilus influenzae pneumonia15 months

Identify the factors associated with severity in Haemophilus influenzae pneumonia. Severity is defined as: oxygen therapy \> 3 L/minute or need for hospitalization in intensive care unit or death.

Antibiotic resistance profiles of Haemophilus influenza strains15 months

Specify the antibiotic resistance profiles of the strains of Haemophilus influenzae responsible for pneumonia during the study period.

Trial Locations

Locations (12)

Hôpital Béclère

🇫🇷

Clamart, France

Hôpital du Kremlin-Bicêtre

🇫🇷

Le Kremlin-Bicêtre, France

Hôpital Lariboisière

🇫🇷

Paris, France

Hôpital Saint-Louis

🇫🇷

Paris, France

Hôpital Beaujon

🇫🇷

Clichy, France

Hôpital Raymond Poincaré

🇫🇷

Garches, France

Hôpital Saint-Antoine

🇫🇷

Paris, France

Hôpital La Pitié Salpêtrière

🇫🇷

Paris, France

Hôpital Cochin

🇫🇷

Paris, France

Hôpital Européen Georges Pompidou

🇫🇷

Paris, France

Hôpital Necker-Enfants Malades

🇫🇷

Paris, France

Hôpital Bichat

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath